China Resources Pharmaceutical Group Limited

China Resources Pharmaceutical Group Limited (CRPG) operates as an investment holding enterprise with core activities spanning the research, development, production, supply, and retail of pharmaceutical and healthcare products across Mainland China and Hong Kong. The company's diverse operations are organized into four primary divisions: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and an 'Others' segment that includes property holding. CRPG's extensive product line features chemical drugs, traditional Chinese medicines, biopharmaceutical agents, and nutritional health items. These cater to a wide array of therapeutic areas, including cardiovascular and cerebrovascular conditions, metabolic and endocrine disorders, respiratory ailments, orthopedics, oncology, pediatric health, and anti-infection treatments, among others. Beyond manufacturing, the company delivers crucial supply chain services such as warehousing, logistics, and value-added solutions to drug producers, hospitals, distributors, and retail pharmacies. As of December 31, 2021, CRPG managed 801 retail pharmacies operating under the CR Care and Teck Soon Hong brands. Its products are also distributed to hospitals and other medical facilities. Founded in 2007 and based in Wan Chai, Hong Kong, the firm was formerly known as China Resources Medications Group Limited until its rebranding in December 2011. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.

CEO: Xiaosong Bai - https://www.crpharm.com